Skip to main content
. 2022 Nov 24;9:951564. doi: 10.3389/fnut.2022.951564

Table 1.

Baseline characteristics of study participants stratified by triglyceride-glucose index quartiles.

Q1 Q2 Q3 Q4 P -value
(≤ 8.26) (8.27–8.65) (8.66–9.08) (≥ 9.09)
N 1955 1956 1955 1956
Age, years 70.90 ± 5.47 71.11 ± 5.43 70.84 ± 5.15 70.51 ± 4.98 0.005
Male, n (%) 967 (49.5) 789 (40.3) 687 (35.1) 730 (37.3) <0.001
Heart rate, bpm 74.95 ± 11.69 75.74 ± 11.51 76.66 ± 11.72 78.72 ± 12.71 <0.001
SBP, mmHg 140.87 ± 19.28 143.27 ± 19.03 145.70 ± 19.19 146.32 ± 19.34 <0.001
DBP, mmHg 79.59 ± 11.26 80.41 ± 11.15 81.84 ± 11.15 82.44 ± 10.83 <0.001
Waist, cm 80.86 ± 9.60 84.21 ± 9.51 86.80 ± 9.41 88.61 ± 8.73 <0.001
BMI, kg/m2 22.52 ± 3.45 23.63 ± 3.49 24.51 ± 3.38 25.19 ± 3.34 <0.001
Hypertension, n (%) 1097 (56.2) 1200 (61.4) 1282 (65.6) 1296 (66.5) <0.001
Diabetes, n (%) 122 (6.2) 241 (12.3) 361 (18.5) 841 (43.0) <0.001
Current smoker, n (%) 265 (13.6) 234 (12.0) 192 (9.8) 211 (10.8) 0.002
Drinking Daily, n (%) 87 (4.5) 69 (3.5) 54 (2.8) 65 (3.3) 0.036
Exercising Daily, n (%) 1134 (58.0) 1159 (59.3) 1250 (63.9) 1238 (63.3) <0.001
Fasting glucose, mmol/L 4.51 [4.08, 4.95] 4.84 [4.36, 5.37] 5.03 [4.53, 5.68] 5.89 [5.02, 7.30] <0.001
Baseline eGFR, mL/min/1.73 m2 83.34 [73.34, 90.14] 81.67 [71.73, 89.46] 82.09 [72.54, 89.96] 82.15 [71.62, 89.79] 0.013
Total cholesterol, mmol/L 5.07 [4.47, 5.78] 5.38 [4.70, 6.11] 5.58 [4.89, 6.34] 5.67 [4.90, 6.54] <0.001
Triglyceride, mmol/L 0.82 [0.69, 0.96] 1.22 [1.07, 1.38] 1.71 [1.50, 1.97] 2.67 [2.14, 3.47] <0.001
Hypertensive treatment, n (%) 323 (23.8) 370 (30.4) 394 (34.2) 454 (42.4) <0.001
Glucose-lowering treatment, n (%) 46 (3.3) 87 (6.9) 118 (9.9) 282 (25.5) <0.001
TyG index 7.96 ± 0.24 8.46 ± 0.11 8.85 ± 0.12 9.56 ± 0.44 <0.001

SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; eGFR: estimated glomerular filtration rate; TyG index, triglyceride-glucose index.